Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials (Q37624213)
scientific article published on 28 October 2009
Language:
(P31) (Q13442814)
(Q815382)
(P50) (Q97551599)
(P275) (Q6936496)
(P304) 2705-2713
(P407) (Q1860)
(P433) 22
(P478) 30
(P577) Wednesday, October 28, 2009
Sunday, November 1, 2009
(P921) (Q181600)
(Q12152)
(Q2476074)
(Q66648976)
(Q423042)
(Q539795)
(Q6822263)
(Q721432)
(P1433) (Q2286839)
(P1476) "Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials" (language: en)
(P2093) Giuseppe De Luca
Paolo Marino
(P2860) (Q28281179)
(Q31155246)
(Q31095779)
(Q28202129)
(Q34523076)
(Q22241926)
(Q27860840)
(Q38521611)
(Q39453386)
(Q40388115)
(Q43209383)
(Q55067861)
(Q43466558)
(Q46114820)
(Q46578993)
(Q46807073)
(Q46466482)
(Q45136309)
(Q45056639)
(Q47811192)
(Q53660192)
(Q56944163)
(Q57764006)
(Q73583534)
(Q74068403)
(Q77836261)
(Q74709449)
(Q77677351)
(P5008) (Q55439927)
(P13046) (Q7318358)
other details
description scientific article published on 28 October 2009

External Links